{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:03:43Z","timestamp":1792634623771,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2015M3A9C8024360"],"award-info":[{"award-number":["NRF-2015M3A9C8024360"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018M3A9C8024360"],"award-info":[{"award-number":["NRF-2018M3A9C8024360"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2014M3C1A3054139"],"award-info":[{"award-number":["NRF-2014M3C1A3054139"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2015R1D1A1A01056620"],"award-info":[{"award-number":["NRF-2015R1D1A1A01056620"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejmech.2018.12.066","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T20:36:57Z","timestamp":1546115817000},"page":"517-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":203,"special_numbering":"C","title":["Recent applications of hydantoin and thiohydantoin in medicinal chemistry"],"prefix":"10.1016","volume":"164","author":[{"given":"SeoHyun","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2510-3025","authenticated-orcid":false,"given":"Dongyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.12.066_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bcp.2008.10.018","article-title":"Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells","volume":"77","author":"Kavitha","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.12.066_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0014-827X(00)00028-8","article-title":"Anti-cancer activity studies of indolalthiohydantoin (PIT) on certain cancer cell lines","volume":"55","author":"Suzen","year":"2000","journal-title":"Il Farmaco"},{"key":"10.1016\/j.ejmech.2018.12.066_bib3","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1016\/j.bmcl.2006.05.010","article-title":"5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity","volume":"16","author":"Carmi","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib4","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1016\/j.bmc.2009.06.004","article-title":"Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: inhibition of VEGF secretion in liver metastatic osteosarcoma cells","volume":"17","author":"Basappa","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib5","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1021\/jm901488g","article-title":"Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)","volume":"53","author":"Jung","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib6","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.bmcl.2011.06.024","article-title":"Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, Part 1","volume":"21","author":"Malancona","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ejmech.2008.06.029","article-title":"Synthesis of amidine and amide derivatives and their evaluation for anti-inflammatory and analgesic activities","volume":"44","author":"Sondhi","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib8","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.intimp.2011.07.010","article-title":"Anti-inflammatory and antinociceptive activities of indole\u2013imidazolidine derivatives","volume":"11","author":"da Silva Guerra","year":"2011","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2018.12.066_bib9","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1016\/j.bmcl.2008.06.081","article-title":"Synthesis of hydantoin analogues of (2S,3R,4S)-4-hydroxyisoleucine with insulinotropic properties","volume":"18","author":"Sergent","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib10","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1016\/j.ejmech.2011.09.032","article-title":"Amine\u2013alkyl derivatives of hydantoin: new tool to combat resistant bacteria","volume":"46","author":"Handzlik","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1248\/cpb.58.1123","article-title":"Antibacterial activity of 5-dialkylaminomethylhydantoins and related compounds","volume":"58","author":"Fujisaki","year":"2010","journal-title":"Chem. Pharmaceut. Bull."},{"key":"10.1016\/j.ejmech.2018.12.066_bib12","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1016\/j.bmc.2011.05.064","article-title":"The discovery of long-acting saligenin \u03b22 adrenergic receptor agonists incorporating hydantoin or uracil rings","volume":"19","author":"Procopiou","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.bmc.2010.11.051","article-title":"Pharmacophore models based studies on the affinity and selectivity toward 5-HT1A with reference to alpha(1)-adrenergic receptors among arylpiperazine derivatives of phenytoin","volume":"19","author":"Handzlik","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib14","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1016\/j.bmc.2008.04.058","article-title":"Synthesis, alpha(1)-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin","volume":"16","author":"Handzlik","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2008.02.024","article-title":"Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins","volume":"44","author":"Zhu","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ardp.201000241","article-title":"Synthesis and anticonvulsant activity of new N-Mannich bases derived from 5-Cyclopropyl-5-phenyl-hydantoins","volume":"344","author":"Byrtus","year":"2011","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2018.12.066_bib17","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/jm001068s","article-title":"Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold","volume":"44","author":"Stilz","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib18","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/S0960-894X(01)00654-0","article-title":"Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection","volume":"11","author":"Kim","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib19","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1016\/S0960-894X(01)00655-2","article-title":"Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection","volume":"11","author":"Kim","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1021\/ml1002647","article-title":"Inhibitors of HCV NS5A: from iminothiazolidinones to symmetrical stilbenes","volume":"2","author":"Romine","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.12.066_bib21","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1021\/ja0104249","article-title":"Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary Technologies:\u2009 evidence for the allosteric inhibition of a Protein\u2212Protein interaction","volume":"123","author":"Last-Barney","year":"2001","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.12.066_bib22","doi-asserted-by":"crossref","first-page":"13757","DOI":"10.1021\/acs.chemrev.7b00067","article-title":"Recent advances in the synthesis of hydantoins: the state of the art of a valuable scaffold","volume":"117","author":"Konnert","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.12.066_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00304940409356627","article-title":"Recent developments in hydantoin chemsitry. A review","volume":"36","author":"Meusel","year":"2004","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.ejmech.2018.12.066_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1573406411666150708111631","article-title":"Synthesis, anticancer evaluation and docking study of 3-benzyloxyhydantoin derivatives","volume":"12","author":"Liu","year":"2016","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/cber.190804101255","article-title":"\u00dcber die Konstitution der Einwirkungsprodukte von substituierten Harnstoffen auf Benzil und \u00fcber einige neue Methoden zur Darstellung der 5.5-Diphenyl-hydantoine","volume":"41","author":"Biltz","year":"1908","journal-title":"Ber. Dtsch. Chem. Ges."},{"key":"10.1016\/j.ejmech.2018.12.066_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/bscb.19840930612","article-title":"Phase-transfer catalysis by poly (ethyleneglycol) 600 in the biltz synthesis of phenytoin","volume":"93","author":"Poupaert","year":"1984","journal-title":"Bull. Soc. Chim. Belg."},{"key":"10.1016\/j.ejmech.2018.12.066_bib27","series-title":"Microwave Assisted Synthesis of 1, 5-disubstituted Hydantoins and Thiohydantoins in Solvent-free Conditions, Synthesis, 2002","first-page":"75","author":"Paul","year":"2002"},{"key":"10.1016\/j.ejmech.2018.12.066_bib28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.tetlet.2011.02.002","article-title":"Facile synthesis of hydantoins and thiohydantoins in aqueous solution","volume":"52","author":"Baccolini","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.12.066_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2012.10.044","article-title":"2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents","volume":"59","author":"Azizmohammadi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib30","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1007\/s00044-013-0597-1","article-title":"Synthesis, single-crystal, in\u00a0vitro antitumor evaluation and molecular docking of 3-substitued 5,5-diphenylimidazolidine-2,4-dione derivatives","volume":"22","author":"Alanazi","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.12.066_bib31","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/j.ejmech.2010.02.038","article-title":"Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction","volume":"45","author":"El-Deeb","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib32","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bmcl.2012.01.036","article-title":"Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones","volume":"22","author":"Abdel-Aziz","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib33","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2298\/JSC110314143T","article-title":"Structure\u2013activity relationships of 3-substituted-5,5-diphenylhydantoins as potential antiproliferative and antimicrobial agents","volume":"76","author":"Tri\u0161ovi\u0107","year":"2011","journal-title":"J.\u00a0Serb. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.12.066_bib34","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.ejmech.2009.01.035","article-title":"5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line","volume":"44","author":"Zuliani","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00706-013-1149-6","article-title":"New derivatives of hydantoin as potential antiproliferative agents: biological and structural characterization in combination with quantum chemical calculations","volume":"145","author":"Hmuda","year":"2014","journal-title":"Monatshefte Fur Chemie"},{"key":"10.1016\/j.ejmech.2018.12.066_bib36","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1016\/j.bmc.2017.10.045","article-title":"Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents","volume":"25","author":"Zhang","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejps.2016.01.010","article-title":"5-Benzylidene-hydantoin is a new scaffold for SIRT inhibition: from virtual screening to activity assays","volume":"85","author":"Sacconnay","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2018.12.066_bib38","first-page":"1535","article-title":"SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2","author":"Peck","year":"2010","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.12.066_bib39","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1016\/j.bmc.2015.10.023","article-title":"Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors","volume":"23","author":"Wang","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib40","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1021\/jm300249m","article-title":"Discovery of diarylhydantoins as new selective androgen receptor modulators","volume":"55","author":"Nique","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib41","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1021\/jm300281x","article-title":"Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator","volume":"55","author":"Nique","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/pros.2990050307","article-title":"The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review","volume":"5","author":"Raynaud","year":"1984","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2018.12.066_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00002512-199303010-00002","article-title":"Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer","volume":"3","author":"Harris","year":"1993","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejmech.2018.12.066_bib44","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejmech.2016.10.049","article-title":"Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer","volume":"125","author":"Zuo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib45","doi-asserted-by":"crossref","first-page":"31866","DOI":"10.1039\/C7RA02142A","article-title":"Novel thiohydantoin analogues bearing the 1-hydroxyl-2,2,2-trifluoro-1-ethyl moiety as androgen receptor inhibitors for the potential treatment of castration resistant prostate cancer","volume":"7","author":"Wang","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.12.066_bib46","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ejmech.2017.10.031","article-title":"Exploring the tetrahydroisoquinoline thiohydantoin scaffold blockade the androgen receptor as potent anti-prostate cancer agents","volume":"143","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib47","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1016\/j.bmc.2016.06.056","article-title":"Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors","volume":"24","author":"Bae","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib48","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/acs.jmedchem.5b00684","article-title":"Inhibition of cancer-associated mutant isocitrate dehydrogenases by 2-thiohydantoin compounds","volume":"58","author":"Wu","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase I inhibitors: camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2018.12.066_bib50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejmech.2015.08.032","article-title":"Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity","volume":"102","author":"Majumdar","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib51","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1158\/1078-0432.CCR-08-0120","article-title":"Targeting the kinesin spindle protein: basic principles and clinical implications","volume":"14","author":"Sarli","year":"2008","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.12.066_bib52","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/ange.200351173","article-title":"HR22C16: a potent small-molecule probe for the dynamics of cell division","volume":"115","author":"Hotha","year":"2003","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib53","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1016\/j.bmcl.2014.10.038","article-title":"Design, synthesis and anticancer evaluation of tetrahydro-beta-carboline-hydantoin hybrids","volume":"24","author":"Shankaraiah","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2018.12.066_bib54","first-page":"S110","article-title":"HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism","volume":"21","author":"Haase","year":"2017","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.ejmech.2018.12.066_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000455166","article-title":"Targeting hypoxia-inducible factors for the treatment of anemia in chronic kidney disease patients","volume":"45","author":"Locatelli","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejmech.2018.12.066_bib56","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm201542d","article-title":"1,3,8-Triazaspiro 4.5 decane-2,4-diones as efficacious Pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia","volume":"55","author":"Vachal","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib57","first-page":"293","article-title":"Activity of fourteen new hydantoin compounds on the human ABCB1 efflux pump","volume":"26","author":"Martins","year":"2012","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.ejmech.2018.12.066_bib58","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.bmc.2016.04.055","article-title":"The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): synthesis, crystallographic and biological studies","volume":"24","author":"\u017bes\u0142awska","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib59","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/j.bmcl.2017.05.062","article-title":"Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors","volume":"27","author":"Tong","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib60","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1016\/j.bmcl.2010.06.134","article-title":"Biaryl substituted hydantoin compounds as TACE inhibitors","volume":"20","author":"Yu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib61","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.bmcl.2010.01.148","article-title":"Discovery and SAR of hydantoin TACE inhibitors","volume":"20","author":"Yu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib62","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbagrm.2013.07.003","article-title":"Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis","volume":"1829","author":"Wang","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"10.1016\/j.ejmech.2018.12.066_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/0929867323666151118120710","article-title":"Peptidyl arginine deiminases and neurodegenerative diseases","volume":"23","author":"Tu","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11064-006-9144-5","article-title":"The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis","volume":"32","author":"Moscarello","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2018.12.066_bib65","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.bmc.2017.03.006","article-title":"Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis","volume":"25","author":"Sarswat","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib66","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1016\/j.bmcl.2013.05.089","article-title":"Hydantoin based inhibitors of MMP13-Discovery of AZD6605","volume":"23","author":"De Savi","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib67","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bmcl.2011.01.036","article-title":"The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis","volume":"21","author":"De Savi","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib68","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.bmcl.2011.04.028","article-title":"Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis","volume":"21","author":"De Savi","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib69","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1021\/jm501522n","article-title":"Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis","volume":"57","author":"Durham","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib70","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1021\/acs.jmedchem.7b00650","article-title":"A\u00a0highly selective hydantoin inhibitor of aggrecanase-1 and aggrecanase-2 with a low projected human dose","volume":"60","author":"Durham","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib71","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.bmc.2014.02.002","article-title":"Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4\/S4 interaction on plasmin","volume":"22","author":"Teno","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib72","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bmcl.2016.03.047","article-title":"Plasmin inhibitors with hydrophobic amino acid-based linker between hydantoin moiety and benzimidazole scaffold enhance inhibitory activity","volume":"26","author":"Teno","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib73","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.bmc.2017.01.040","article-title":"Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists","volume":"25","author":"Teno","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib74","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bmcl.2015.01.047","article-title":"Design and discovery of 2-oxochromene derivatives as liver X receptor \u03b2-selective agonists","volume":"25","author":"Matsuda","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib75","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.bmcl.2015.04.080","article-title":"Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor \u03b2-selective agonists","volume":"25","author":"Koura","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib76","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1016\/j.bmc.2016.05.048","article-title":"Discovery of a 2-hydroxyacetophenone derivative as an outstanding linker to enhance potency and \u03b2-selectivity of liver X receptor agonist","volume":"24","author":"Koura","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib77","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/j.bmc.2014.04.036","article-title":"The design and synthesis of novel SGLT2 inhibitors: C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties","volume":"22","author":"Guo","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejmech.2015.08.037","article-title":"Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors","volume":"103","author":"Wang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib79","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1016\/j.bmcl.2009.09.020","article-title":"Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects","volume":"19","author":"Bhattarai","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.12.066_bib80","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1016\/j.bmc.2007.05.027","article-title":"5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases","volume":"15","author":"Maccari","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib81","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.bmc.2009.01.044","article-title":"5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors","volume":"17","author":"Ottan\u00e0","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib82","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1248\/cpb.c14-00017","article-title":"Synthesis of new 5-substituted hydantoins and symmetrical twin-drug type hydantoin derivatives","volume":"62","author":"Fujisaki","year":"2014","journal-title":"Chem. Pharmaceut. Bull."},{"key":"10.1016\/j.ejmech.2018.12.066_bib83","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1248\/cpb.57.1415","article-title":"Preparation and chemical properties of 5-dialkylaminomethylhydantoins and 2-thio-analogues","volume":"57","author":"Fujisaki","year":"2009","journal-title":"Chem. Pharmaceut. Bull."},{"key":"10.1016\/j.ejmech.2018.12.066_bib84","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1248\/cpb.c13-00461","article-title":"Antibacterial activity of some 5-dialkylaminomethylhydantoins and related derivatives","volume":"61","author":"Fujisaki","year":"2013","journal-title":"Chem. Pharmaceut. Bull."},{"key":"10.1016\/j.ejmech.2018.12.066_bib85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cclet.2015.10.027","article-title":"Synthesis and antibacterial activity of Schiff bases of 5-substituted isatins","volume":"27","author":"Haj Mohammad Ebrahim Tehrani","year":"2016","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.12.066_bib86","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s00044-017-1907-9","article-title":"Synthesis and anti(myco)bacterial activity of novel 5,5-diphenylpyrrolidine N-aroylthiourea derivatives and a functionalized hexahydro-1H-pyrrolo 1,2-c imidazole","volume":"26","author":"Ersen","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.12.066_bib87","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1021\/acs.jmedchem.7b00847","article-title":"Membrane-active hydantoin derivatives as antibiotic agents","volume":"60","author":"Su","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib88","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coph.2006.04.006","article-title":"Antibacterial peptides for therapeutic use: obstacles and realistic outlook","volume":"6","author":"Marr","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.12.066_bib89","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2018.12.066_bib90","doi-asserted-by":"crossref","first-page":"11234","DOI":"10.1039\/C4CC02916J","article-title":"Identification of bromophenol thiohydantoin as an inhibitor of DisA, a c-di-AMP synthase, from a 1000 compound library, using the coralyne assay","volume":"50","author":"Zheng","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2018.12.066_bib91","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1016\/j.tet.2015.10.073","article-title":"Structure-activity relationship studies of c-di-AMP synthase inhibitor, bromophenol-thiohydantoin","volume":"72","author":"Zheng","year":"2016","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.12.066_bib92","first-page":"223","article-title":"The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus","volume":"26","author":"Dymek","year":"2012","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.ejmech.2018.12.066_bib93","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bmc.2012.10.053","article-title":"Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin","volume":"21","author":"Handzlik","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib94","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1021\/acsmedchemlett.7b00230","article-title":"1-Benzyl-3-aryl-2-thiohydantoin derivatives as new anti-trypanosoma brucei agents: SAR and in\u00a0vivo efficacy","volume":"8","author":"Buchynskyy","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.12.066_bib95","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/1475-2875-13-452","article-title":"Artemisinin resistance \u2013 modelling the potential human and economic costs","volume":"13","author":"Lubell","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2018.12.066_bib96","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmech.2014.07.048","article-title":"Discovery of highly selective 7-chloroquinoline-thiohydantoins with potent antimalarial activity","volume":"84","author":"Raj","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib97","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1016\/j.bmc.2015.02.050","article-title":"Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents","volume":"23","author":"Meyers","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib98","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/jm901414e","article-title":"Design and synthesis of 5,5\u2032-disubstituted aminohydantoins as potent and selective human \u03b2-secretase (BACE1) inhibitors","volume":"53","author":"Malamas","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib99","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1021\/jm800914n","article-title":"Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of \u03b2-secretase","volume":"51","author":"Barrow","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib100","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.bmc.2015.12.050","article-title":"Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives","volume":"24","author":"Ivanenkov","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib101","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/ardp.201500272","article-title":"Design and synthesis of novel phenylpiperazine derivatives as potential anticonvulsant agents","volume":"348","author":"Habib","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2018.12.066_bib102","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1016\/j.bmc.2011.08.017","article-title":"Synthesis and anticonvulsant activity of new N-Mannich bases derived from 5-cyclopropyl-5-phenyl- and 5-cyclopropyl-5-(4-chlorophenyl)-imidazolidine-2,4-diones","volume":"19","author":"Byrtus","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib103","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.pharep.2016.04.018","article-title":"Design, synthesis, anticonvulsant, and antiarrhythmic properties of novel N-Mannich base and amide derivatives of \u03b2-tetralinohydantoin","volume":"68","author":"Czopek","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2018.12.066_bib104","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2014.01.065","article-title":"SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT7 receptor ligands among phenylpiperazine hydantoin derivatives","volume":"78","author":"Handzlik","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejmech.2016.02.024","article-title":"Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation","volume":"112","author":"Kucwaj-Brysz","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib106","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2174\/157018012800673092","article-title":"Synthesis and evaluation of anti-inflammatory and antitussive activity of hydantion derivatives","volume":"9","author":"Lu","year":"2012","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2018.12.066_bib107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s40242-012-2064-9","article-title":"Synthesis and antitussive effect of new hydantoin compounds","volume":"29","author":"Zhang","year":"2013","journal-title":"Chem. Res. Chin. Univ."},{"key":"10.1016\/j.ejmech.2018.12.066_bib108","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1016\/j.bmc.2012.08.062","article-title":"Small-molecular inhibitors of Ca2+-induced mitochondrial permeability transition (MPT) derived from muscle relaxant dantrolene","volume":"20","author":"Murasawa","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib109","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejmech.2012.09.029","article-title":"Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel \u03b2-carboline derivatives","volume":"57","author":"Ahmed","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ardp.201200334","article-title":"Design of novel beta-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors","volume":"346","author":"El-Gamil","year":"2013","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2018.12.066_bib111","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ejmech.2018.09.028","article-title":"Discovery of furyl\/thienyl \u03b2-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect","volume":"158","author":"Zheng","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib112","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1039\/C4MD00171K","article-title":"Benzylidene-linked thiohydantoin derivatives as inhibitors of tyrosinase and melanogenesis: importance of the beta-phenyl-alpha,beta-unsaturated carbonyl functionality","volume":"5","author":"Kim","year":"2014","journal-title":"Medicinal Chemistry Communications"},{"key":"10.1016\/j.ejmech.2018.12.066_bib113","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.bmc.2012.02.009","article-title":"Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with \u03b11-adrenoceptor affinities","volume":"20","author":"Handzlik","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.066_bib114","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1016\/j.bmc.2012.05.064","article-title":"Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with \u03b11-adrenoceptor antagonistic properties","volume":"20","author":"Handzlik","year":"2012","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418311115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418311115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:52:43Z","timestamp":1759326763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418311115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":114,"alternative-id":["S0223523418311115"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.066","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent applications of hydantoin and thiohydantoin in medicinal chemistry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}